Skip to main content
GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
India flag India · Delayed Price · Currency is INR
2,412.00
-27.20 (-1.12%)
Apr 28, 2026, 3:29 PM IST

NSE:GLAXO Revenue

GlaxoSmithKline Pharmaceuticals had revenue of 10.41B INR in the quarter ending December 31, 2025, with 9.67% growth. This brings the company's revenue in the last twelve months to 38.01B, up 2.59% year-over-year. In the fiscal year ending March 31, 2025, GlaxoSmithKline Pharmaceuticals had annual revenue of 37.49B with 8.56% growth.

Revenue (ttm)
38.01B
Revenue Growth
+2.59%
P/S Ratio
10.74
Revenue / Employee
12.21M
Employees
3,113
Market Cap
408.37B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202537.49B2.96B8.56%
Mar 31, 202434.54B2.02B6.21%
Mar 31, 202332.52B-263.06M-0.80%
Mar 31, 202232.78B3.52B12.05%
Mar 31, 202129.26B-2.99B-9.27%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 568.09B
Divi's Laboratories 103.14B
Apollo Hospitals Enterprise 242.15B
Cipla 279.67B
Biocon 168.27B
Anthem Biosciences 20.02B
Ipca Laboratories 95.06B
Aster DM Healthcare 44.61B
Revenue Rankings

GlaxoSmithKline Pharmaceuticals News

More News